Live Cell Imaging Market Companies
Among the leading companies in the live cell imaging market are ZEISS GROUP, Nikon Corporation Healthcare, Revvity, and Thermo Fisher Scientific Inc. Investing in technological advancements such as AI-powered image analysis, high-resolution microscopy, and automation to boost efficiency and precision will be a primary focus for live cell imaging companies. Additionally, businesses will focus on expanding their product line by developing user-friendly and reasonably priced solutions for a variety of research applications, catering to both smaller academic labs and large pharmaceutical companies.
List of Key Players in the Market:
- Thermo Fisher Scientific Inc.
- Revvity.
- DH Life Sciences, LLC
- LEICA MICROSYSTEMS
- ZEISS GROUP
- Merck KGaA
- EVIDENT
- Nikon Corporation Healthcare
- Sartorius AG
- Agilent Technologies, Inc.
- Leica Microsystems
- Thorlabs, Inc.
- JEOL Ltd.
- BD
Recent News:
- A new live-cell imaging system from Durham-based Ramona, a supplier of cutting-edge imaging technologies for the bio sciences, greatly increases throughput and speed for cell analysis on February 2025. Artificial intelligence-powered real-time image processing and miniature video microscopes are features of the Vireo system. Vireo can assist in providing scientists with better, quicker insights into drug discovery.
- Leading international medical technology company BD announced the commercial launch of a novel cell sorting device with two innovative technologies that allow scientists to find more detailed information about cells than was previously possible in conventional flow cytometry experiments on May 2023.
- Axion BioSystems announced that the Omni Pro 12 has joined the Omni family of live-cell imaging products on January 2023. The new platform gives researchers and drug developers doing live-cell imaging tests more flexibility and efficiency. It has integrated robotics and a multiplate architecture that works with any conventional incubator.